November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
November 2, 2018 — In a new study, acute heart failure patients who received individualized treatment by blood volume ...
November 1, 2018 — Daxor Corp. has entered an agreement with CHF Solutions to explore clinical synergies between Daxor’s ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 29, 2018 — The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is ...

October 19, 2018 — Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...
From a cardiovascular device innovation standpoint, the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference ...
A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston ...
October 4, 2018 — The Ohio State University Wexner Medical Center is first in the country to test a new medical device ...

One of the key, early pioneers who helped bring coronary angioplasty to the United States in the late 1970s was Simon ...
September 28, 2018 — Heart failure patients who received the Carillon Mitral Contour System in the REDUCE FMR clinical ...
William Abraham, M.D., FACC, professor of medicine and director of the division of cardiovascular medicine, The Ohio ...
September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early ...
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal ...
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival ...